What Is Cefixime 200mg + Ofloxacin 200mg Used For?

CEFEXOTIME 0 is the brand name supplied for a pharmaceutical product containing Cefixime 200mg + Ofloxacin 200mg. It combines two antibacterial agents from different antibiotic classes, each working through a distinct mechanism to interfere with bacterial survival and multiplication.

Cefixime belongs to the third-generation cephalosporin group. It works by interfering with bacterial cell-wall formation. Ofloxacin belongs to the fluoroquinolone group and inhibits bacterial enzymes responsible for DNA replication and repair

For patients, pharmacists and healthcare professionals researching CEFEXOTIME 0, understanding its composition, indications, safety profile and limitations is essential before considering its use.

 Why Is Cefixime 200mg + Ofloxacin 200mg Important?

The two ingredients belong to different antibacterial classes and act on separate bacterial targets.

• Cefixime 200mg: Interferes with bacterial cell-wall synthesis.
• Ofloxacin 200mg: Interferes with bacterial DNA replication and repair.

Their pharmacological actions are different, but both are intended to act against susceptible bacteria.

Antibiotic selection is particularly important in India, where antimicrobial resistance is an important public-health concern. A combination should only be considered when there is a clear clinical rationale for using both ingredients.

Responsible prescribing helps reduce unnecessary antibiotic exposure, avoid preventable adverse reactions and preserve the effectiveness of existing antibacterial medicines.

 Key Benefits of Cefixime 200mg + Ofloxacin 200mg

CEFEXOTIME 0 brings together two established antibacterial ingredients. The following are pharmacological characteristics, not guaranteed clinical outcomes of the fixed-dose product.

H3: What Are the Benefits of Cefixime and Ofloxacin?

1. Different mechanisms of action: Cefixime affects bacterial cell-wall synthesis, while ofloxacin interferes with bacterial DNA processing.
2. Different antibiotic classes: The ingredients belong to the cephalosporin and fluoroquinolone families.
3. Established individual pharmacology: Both ingredients have recognised antibacterial activity against selected susceptible organisms.
4. Fixed-dose formulation: Combining ingredients into one formulation may offer convenience when a clinician has determined that both are necessary.
5. Prescription-based treatment: Appropriate antibiotic selection can help manage susceptible bacterial infections when supported by clinical assessment.

The combination should not be described as universally superior, faster acting or effective against all bacterial infections without reliable product-specific evidence.

 Indications of Cefixime 200mg + Ofloxacin 200mg

The indication for CEFEXOTIME 0 must be established by a qualified healthcare professional.

Cefixime individually has recognised prescribing uses for selected infections caused by susceptible organisms, including certain uncomplicated urinary tract infections, pharyngitis and tonsillitis. Ofloxacin has separate indication-specific uses and important safety restrictions.

These individual indications do not automatically establish an indication for the fixed-dose combination.

INDICATIONS, EFFICACY AND CLINICAL EVIDENCE

The clinical evaluation of this combination should consider three important factors:

• Indications: Is there a bacterial infection for which both ingredients are genuinely required?
• Efficacy: Are the causative organisms susceptible to the selected antibiotics?
• Clinical evidence: Are there adequate controlled studies supporting the combination for the specific condition?

A published South Indian hospital-based antibiotic stewardship study examined cefixime 200mg + ofloxacin 200mg among non-standard fixed-dose antibiotic combinations. The study raised concerns about insufficient randomised controlled trial evidence supporting certain uses, including some gastrointestinal and other conditions.

Consequently, the efficacy of the individual ingredients should not be presented as proof of the clinical effectiveness of CEFEXOTIME 0 for every proposed indication.

 Mechanism of Action of Cefixime 200mg + Ofloxacin 200mg

Cefixime mechanism of action: Cefixime binds to penicillin-binding proteins (PBPs), interfering with the final stages of peptidoglycan cross-linking during bacterial cell-wall synthesis. This weakens the cell wall and can cause the death of susceptible bacteria.

Ofloxacin mechanism of action: Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV. These enzymes are essential for DNA replication, repair and chromosome separation. Their inhibition disrupts bacterial genetic processes and can result in bacterial cell death.

Combined pharmacological activity

Composition	Drug class	Main mechanism
Cefixime 200mg	Third-generation cephalosporin	Inhibition of bacterial cell-wall synthesis
Ofloxacin 200mg	Fluoroquinolone	Inhibition of DNA gyrase and topoisomerase IV

Although the ingredients have different mechanisms, clinical synergy or improved treatment outcomes cannot be assumed without appropriate studies.

 Side Effects 

Possible side effects associated with these ingredients include:

• Nausea and vomiting.
• Diarrhoea or loose stools.
• Abdominal discomfort.
• Indigestion.
• Headache.
• Dizziness.
• Skin rash.
• Allergic reactions.

Not every patient experiences these reactions. Their occurrence and severity can depend on individual susceptibility, dosage, medical history and other medicines.

Serious Side Effects of Cefixime and Ofloxacin

Ofloxacin has important fluoroquinolone safety warnings.

1. Tendinitis and tendon rupture: Pain, swelling or tenderness around tendons, particularly the Achilles tendon, requires immediate medical attention.

2. Peripheral neuropathy: Tingling, burning, numbness or weakness in the arms or legs can indicate nerve-related adverse effects.

3. Central nervous system reactions: Severe dizziness, confusion, agitation, seizures or unusual behavioural changes require urgent assessment.

4. Severe allergic reactions: Facial swelling, throat swelling, difficulty breathing or widespread hives require emergency medical attention.

5. Severe diarrhoea: Persistent or bloody diarrhoea may indicate antibiotic-associated colitis.

6. Heart rhythm problems: Ofloxacin can contribute to QT-interval prolongation in susceptible patients.

7. Myasthenia gravis exacerbation: Ofloxacin may worsen muscle weakness in individuals with myasthenia gravis.

Patients experiencing suspected serious reactions should seek immediate medical advice.

 Available Substitutes for Cefixime 200mg + Ofloxacin 200mg

There is no universally interchangeable substitute for this fixed-dose combination.

Depending on the diagnosis and susceptibility results, a clinician may consider:

• Cefixime-only formulations.
• Other appropriately selected cephalosporins.
• Ofloxacin-only formulations where clinically justified.
• Other guideline-supported antibacterial medicines.

A substitute must be selected according to the infection, patient history, kidney function, allergies and local resistance patterns.

A medicine containing only cefixime is not equivalent to a medicine containing cefixime and ofloxacin. Patients should not switch antibiotic brands independently.

 Dosage Guidelines for CEFEXOTIME 0

The appropriate dosage and duration depend on the infection, the patient's age, kidney function, clinical condition and bacterial susceptibility.

There is no universal dosage schedule that can safely be recommended for this fixed-dose combination across all indications.

The prescribing doctor should determine whether both ingredients are necessary and whether their fixed strengths are suitable for the individual patient.

General precautions include:

• Take the medicine only when prescribed.
• Follow the prescribed frequency and duration.
• Do not double a missed dose without professional advice.
• Do not share antibiotics.
• Do not use leftover medicines for a new illness.
• Inform the doctor if symptoms worsen or adverse effects develop.

 Precautions and Warnings

Before using CEFEXOTIME 0, inform the healthcare professional about:

• Previous allergies to cephalosporins, penicillins or quinolones.
• Kidney disease or impaired renal function.
• Pregnancy or breastfeeding.
• Previous tendon injuries.
• Myasthenia gravis.
• Heart rhythm disorders.
• Diabetes and medicines that affect blood glucose.
• Previous neurological disorders.
• Corticosteroid use.
• All other prescription medicines, supplements and vitamins.

Ofloxacin absorption may be reduced by products containing iron, zinc, calcium, magnesium or aluminium when taken too close together. Ask a pharmacist about appropriate separation.

Pregnant patients, breastfeeding mothers, children and older adults require particular attention to the risks and suitability of the ingredients.

Antibiotics should never be self-prescribed for common colds, viral fever or undiagnosed diarrhoea.

 CEFEXOTIME 0 by Steris Healthcare – Product Information

CEFEXOTIME 0 is the requested brand name associated with Steris Healthcare for this article.

Before publishing commercial product information, verify the manufacturer's or marketer's identity, product packaging, actual composition, manufacturing licence, applicable regulatory status and approved product information.

For healthcare professionals, distributors and pharmacists in India, transparent product communication is important for responsible dispensing and patient awareness.

A trustworthy pharmaceutical product page should provide accurate composition information, relevant safety warnings, clinical references and clear guidance about prescription-based use.

Frequently Asked Questions 

1. What is CEFEXOTIME 0 used for?

CEFEXOTIME 0 is the supplied brand name for cefixime 200mg + ofloxacin 200mg. Its use must be determined by a doctor according to the bacterial infection and clinical evidence.

2. What is the composition of CEFEXOTIME 0?

Its stated composition is Cefixime 200mg + Ofloxacin 200mg.

3. Is CEFEXOTIME 0 an antibiotic?

Yes. Both ingredients are antibacterial medicines belonging to different antibiotic classes.

4. What is cefixime 200mg used for?

Cefixime is used for selected bacterial infections caused by susceptible organisms, according to its prescribing information.

5. What is ofloxacin 200mg used for?

Ofloxacin is a fluoroquinolone antibiotic used for selected susceptible bacterial infections, subject to important safety restrictions.

6. Can CEFEXOTIME 0 treat loose motions?

It should not be routinely used for loose motions. Most diarrhoea does not require antibiotics, and treatment depends on the underlying cause.

7. Is cefixime and ofloxacin effective for UTI?

The ingredients have antibacterial activity against selected susceptible organisms, but this combination is not automatically the preferred treatment. Clinical assessment and urine culture may help guide therapy.

8. What is the mechanism of action of cefixime?

Cefixime inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins.

9. What is the mechanism of action of ofloxacin?

Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and repair.

10. What are the common side effects?

Possible side effects include nausea, diarrhoea, vomiting, abdominal discomfort, headache and dizziness.

11. Can CEFEXOTIME 0 cause tendon pain?

Yes. Ofloxacin is associated with tendinitis and tendon rupture. New tendon pain or swelling requires prompt medical attention.

12. Is CEFEXOTIME 0 safe during pregnancy?

It should not be used during pregnancy without specialist medical advice and an assessment of suitable alternatives.

13. Can breastfeeding mothers take this combination?

Breastfeeding patients should consult their doctor before using either ingredient.

14. Can children use CEFEXOTIME 0?

Children should not receive this combination without specialist assessment because of the safety considerations associated with ofloxacin and the fixed-dose formulation.

15. What are the alternatives to CEFEXOTIME 0?

Alternatives may include selected single-agent antibiotics or other guideline-supported treatments. The appropriate choice depends on diagnosis and susceptibility.

16. Does this combination work against viral infections?

No. Antibiotics do not treat viral infections such as common colds and influenza.

17. Can two antibiotics provide better results than one?

Not necessarily. A two-antibiotic combination is not automatically more effective and may increase unnecessary exposure and adverse effects.

18. What precautions are needed while taking ofloxacin?

Patients should be aware of tendon pain, nerve symptoms, neurological reactions and possible heart rhythm problems. All existing medical conditions and medicines should be disclosed to the doctor.

19. Is CEFEXOTIME 0 a prescription medicine?

It should be treated as a prescription antibiotic combination. Its exact regulatory and dispensing status should be verified against applicable Indian requirements and product documentation.

20. Is there strong clinical evidence for Cefixime 200mg + Ofloxacin 200mg?

The individual ingredients have established pharmacology, but the evidence for their fixed-dose combination must be evaluated separately for each indication. A South Indian stewardship study has raised concerns about inadequate controlled-trial evidence for certain uses.

Conclusion

CEFEXOTIME 0, with the stated composition of Cefixime 200mg + Ofloxacin 200mg, combines two antibacterial ingredients that act through different mechanisms. Cefixime interferes with bacterial cell-wall formation, while ofloxacin disrupts bacterial DNA replication and repair.

Although both ingredients have established antibacterial properties, their combination should not be considered a universal treatment for bacterial infections. Appropriate clinical indications, bacterial susceptibility, individual safety considerations and reliable clinical evidence must guide treatment decisions.

For Further Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now